In the ongoing patent saga between Camtek and Orbotech, two Israeli manufacturers of optical imaging systems for quality control of semiconductor substrates, Camtek, represented by Adv. Adi Levit, petitioned to correct the statement of case concerning their opposition to Orbotech’s… Read More ›
In Febrary 2007, Israel patent Number 171865 to Speedline technologies, titled METHOD AND APPARATUS FOR SIMULTANEOUS INSPECTION AND CLEANING OF A STENCIL published for opposition purposes, and an opposition was filed in may 2007. It has now, six years later been withdrawn…. Read More ›
Eli Shafir owned three registered designs – 44798, 44799 and 44800. On suing A. A. Maayanot LTD. for infringement in the Haifa District Court, A. A. Maayanot LTD. filed a cancellation action in the Israel Patent Office. Judge Dr. Adi… Read More ›
Camtek successfully opposes Orbotech patent number IL 142028 titled “Pixel Coding and Processing Method” before the Israel Patent Office
Filing, prosecuting and maintaining patents in Israel has just got more expensive
The State of Israel is suing researchers of the Volcani Agricultural Research Institute who filed patent applications privately, for inventions that the State considers to be service inventions of civil servants.
Omrix Biopharmaceutials filed a patent opposition against IL 157360 to CSL Behring. The patent application opposed is titled “Storage- Stable Liquid Fibrinogen Formulation and Uses Thereof” In response to the Opposition being filed, which was based largely on a corresponding… Read More ›
Patent Extensions for Pharmaceutical Compositions in Israel Cannot be Obtained on the Back of Patent Term Extensions in the US, Due to TRIPS change in Law to 20 years from filing
Request to extend patent term for Aranesp in Israel rejected by Israel Patent Office.
There have been some substantive changes to both the Israel and US patent law and practice recently. In the US, there is now a procedure for oppositions. Israel applications now publish before allowance and third parties can submit prior art to… Read More ›